SRx Health Solutions, Inc. (SRXH) Form 424B3 — Jun 5, 2026
SRx Health Solutions, Inc. (SRXH) filed a prospectus supplement registering up to 2,506,893,959 shares of common stock for resale by Keystone Capital Partners, LLC. This massive block of shares, issuable under an existing equity line agreement, represents extreme potential dilution to existing shareholders if sold. Concurrently, the company completed the initial closing of a private placement, raising approximately $4.53 million through the sale of 5,660 shares of Series B Convertible Preferred Stock and warrants to purchase 22.2 million shares of common stock.
Key figures
- Offering Price
- 0.13
- Shares Offered
- 2506893959
- Warrants issued
- 22237666
- Conversion price
- 0.3182
- Series b shares issued
- 5660
- Warrant exercise price
- 0.3182
- Private placement amount
- 8000000
- Stated value per preferred share
- 1000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.